UY27014A1 - Compuestos antitumorales activados por fap ii - Google Patents
Compuestos antitumorales activados por fap iiInfo
- Publication number
- UY27014A1 UY27014A1 UY27014A UY27014A UY27014A1 UY 27014 A1 UY27014 A1 UY 27014A1 UY 27014 A UY27014 A UY 27014A UY 27014 A UY27014 A UY 27014A UY 27014 A1 UY27014 A1 UY 27014A1
- Authority
- UY
- Uruguay
- Prior art keywords
- fapalfa
- fap
- prodrug
- physiological conditions
- under physiological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0027552.9A GB0027552D0 (en) | 2000-11-10 | 2000-11-10 | Anti-tumor compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY27014A1 true UY27014A1 (es) | 2002-07-31 |
Family
ID=9902983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY27014A UY27014A1 (es) | 2000-11-10 | 2001-11-07 | Compuestos antitumorales activados por fap ii |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR031316A1 (fr) |
| AU (1) | AU2002220684A1 (fr) |
| GB (1) | GB0027552D0 (fr) |
| UY (1) | UY27014A1 (fr) |
| WO (1) | WO2002038590A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1963537A4 (fr) * | 2005-12-14 | 2009-11-11 | Ludwig Inst For Cancer Res Ltd | Procede permettant de diagnostiquer une arthrite rhumatoide par le dosage des synoviocytes de type fibroblastique pour la proteine d'activation des fibroblastes |
| DK2525830T3 (en) | 2010-01-22 | 2016-08-15 | Ascendis Pharma As | DIPEPTID-BASED PRODRUG LINKERS TO ALIFATIC AMINE-CONTAINING MEDICINES |
| US20130030359A1 (en) | 2010-01-22 | 2013-01-31 | Ascendis Pharma A/S | Dipeptide-based prodrug linkers for aromatic amine-containing drugs |
| AU2013369261B2 (en) | 2012-12-28 | 2018-08-09 | Cobiores Nv | Minimally toxic prodrugs |
| HUE063194T2 (hu) * | 2014-06-13 | 2024-01-28 | Bach Biosciences Llc | FAP-aktivált terápiás szerek és az azokkal kapcsolatos felhasználások |
| US9737556B2 (en) | 2014-06-13 | 2017-08-22 | Trustees Of Tufts College | FAP-activated therapeutic agents, and uses related thereto |
| EP3565560B1 (fr) | 2017-01-09 | 2024-05-29 | OnkosXcel Therapeutics, LLC | Procédés prédictifs et diagnostiques pour le cancer de la prostate |
| EP4267188A1 (fr) | 2020-12-22 | 2023-11-01 | Cobiores NV | Composés comprenant une fraction tétrapeptidique |
| WO2022167664A1 (fr) | 2021-02-07 | 2022-08-11 | Cobiores Nv | Composés comprenant une fraction tétrapeptidique |
| CN120590466A (zh) * | 2025-08-06 | 2025-09-05 | 首都医科大学脑重大疾病研究中心(北京脑重大疾病研究院) | 一种靶向成纤维细胞活化蛋白的化合物及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5866679A (en) * | 1994-06-28 | 1999-02-02 | Merck & Co., Inc. | Peptides |
| EP0855910A4 (fr) * | 1995-10-18 | 2000-07-05 | Merck & Co Inc | Conjugues utiles pour traiter l'adenome prostatique benin |
| US6613879B1 (en) * | 1999-05-14 | 2003-09-02 | Boehringer Ingelheim Pharma Kg | FAP-activated anti-tumour compounds |
-
2000
- 2000-11-10 GB GBGB0027552.9A patent/GB0027552D0/en not_active Ceased
-
2001
- 2001-11-06 AU AU2002220684A patent/AU2002220684A1/en not_active Abandoned
- 2001-11-06 WO PCT/EP2001/012812 patent/WO2002038590A1/fr not_active Ceased
- 2001-11-07 UY UY27014A patent/UY27014A1/es not_active Application Discontinuation
- 2001-11-09 AR ARP010105240A patent/AR031316A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002038590A1 (fr) | 2002-05-16 |
| AR031316A1 (es) | 2003-09-17 |
| AU2002220684A1 (en) | 2002-05-21 |
| GB0027552D0 (en) | 2000-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033792A1 (es) | Compuestos anti - tumorales activados por paf | |
| HN1999000124A (es) | Derivados de pirazol substituido. | |
| CR7171A (es) | Composiciones farmaceuticas de farmacos y polimeros acidos neutralizados | |
| DE602006014990D1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| UY27939A1 (es) | Compuestos | |
| BR0208636A (pt) | Agente terapêutico para doenças de artrìtides crÈnicas de doenças relacionadas com infncia | |
| BR0306513A (pt) | tampão com medicamento | |
| UY27878A1 (es) | Derivados de indolinfenilsulfonamida | |
| UY27014A1 (es) | Compuestos antitumorales activados por fap ii | |
| ES2067696T3 (es) | Composiciones de liberacion sostenida para tratar la enfermedad periodontal. | |
| BRPI0411900B8 (pt) | compostos e composições farmacêuticas compreendendo os mesmos | |
| UY28294A1 (es) | Dihidroquinazolinas sustituidas | |
| ES2267706T3 (es) | Agentes como la nicotinamida o cardr para el tratamiento de trastornos de la piel. | |
| PT1411938E (pt) | Utilizacao da ciclopamina para a preparacao de um medicamento para o tratamento de psoriase | |
| ECSP045353A (es) | Derivados de benzoxazinona, su preparación y aplicación como medicamentos | |
| PT1216707E (pt) | Novas utilizacoes terapeuticas para um smr-1-peptideo | |
| HN2000000045A (es) | Nuevas combinaciones farmaceuticas para inhibidores de la nos. | |
| UY27451A1 (es) | 2,5-diamidoindoles sustituidos y su utilización | |
| PT1331940E (pt) | Utilizacao da pentraxina longa ptx3 para o tratamento de doencas provocadas por uma activacao alterada do factor de crescimento fgf-2 | |
| PA8661701A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
| SV2003001061A (es) | Nuevos heterociclos 3 ref.lea 35361-sv | |
| HN2001000204A (es) | Amidas de acido fenilciclohexanocarboxilico sustituido y su uso | |
| SV2002000639A (es) | Alcanosulfonatos de fenoxifenilo ref. lea 34813-sv | |
| HN2000000078A (es) | Amidas sustituidas del acido fenilciclohexanocarboxilico y su uso como inhibidores de la incorporacion de adenosina | |
| HN2000000072A (es) | Amidas de acidos fenilciclohexanocarboxilicos sustituidos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20150126 |